CN112118833B - 适用于活性药物成分的崩解经口片剂 - Google Patents

适用于活性药物成分的崩解经口片剂 Download PDF

Info

Publication number
CN112118833B
CN112118833B CN201980032280.5A CN201980032280A CN112118833B CN 112118833 B CN112118833 B CN 112118833B CN 201980032280 A CN201980032280 A CN 201980032280A CN 112118833 B CN112118833 B CN 112118833B
Authority
CN
China
Prior art keywords
oral tablet
particles
sugar alcohol
tablet
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980032280.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN112118833A (zh
Inventor
赫勒·维托夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fertin Pharma AS
Original Assignee
Fertin Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma AS filed Critical Fertin Pharma AS
Publication of CN112118833A publication Critical patent/CN112118833A/zh
Application granted granted Critical
Publication of CN112118833B publication Critical patent/CN112118833B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201980032280.5A 2018-05-17 2019-05-15 适用于活性药物成分的崩解经口片剂 Active CN112118833B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/982,556 US11058633B2 (en) 2018-05-17 2018-05-17 Disintegrating oral tablet suitable for active pharmaceutical ingredients
US15/982,556 2018-05-17
PCT/DK2019/050154 WO2019219144A1 (en) 2018-05-17 2019-05-15 Disintegrating oral tablet suitable for active pharmaceutical ingredients

Publications (2)

Publication Number Publication Date
CN112118833A CN112118833A (zh) 2020-12-22
CN112118833B true CN112118833B (zh) 2023-03-03

Family

ID=66793733

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980032280.5A Active CN112118833B (zh) 2018-05-17 2019-05-15 适用于活性药物成分的崩解经口片剂

Country Status (7)

Country Link
US (3) US11058633B2 (cg-RX-API-DMAC10.html)
EP (1) EP3793531A1 (cg-RX-API-DMAC10.html)
JP (1) JP7475286B2 (cg-RX-API-DMAC10.html)
CN (1) CN112118833B (cg-RX-API-DMAC10.html)
AU (1) AU2019269881B2 (cg-RX-API-DMAC10.html)
CA (1) CA3096339C (cg-RX-API-DMAC10.html)
WO (1) WO2019219144A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US12702643B2 (en) * 2019-10-11 2026-08-11 Fertin Pharma A/S Ion-exchange composition with water-soluble mucoadhesive polymers
CA3159297A1 (en) * 2019-12-09 2021-06-17 Jr. Darrell Eugene Holton Oral products with controlled release
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
AU2021268062B2 (en) * 2020-05-08 2024-08-15 Fertin Pharma A/S Flowpack for oral delivery of active ingredients
AR123872A1 (es) * 2020-10-23 2023-01-18 Hk Inno N Corp Comprimido de desintegración oral, procedimiento de preparación del mismo, procedimiento para prevenir o tratar enfermedades y uso del mismo
CN113041228A (zh) * 2021-03-30 2021-06-29 新乡市常乐制药有限责任公司 一种他达拉非片剂混合物及其制备方法
US11786473B2 (en) * 2021-12-14 2023-10-17 Fertin Pharma A/S Nicotine tablet
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
DK182278B1 (en) * 2023-07-07 2026-02-04 Fertin Pharma As Dissolvable orally adhering tablet
DK182273B1 (en) * 2023-07-07 2026-01-30 Fertin Pharma As Dissolvable orally adhering nicotine tablet
WO2024186829A2 (en) * 2023-03-07 2024-09-12 Bayer Healthcare Llc Orally disintegrating tablet and methods of making thereof
AU2024296756A1 (en) * 2023-07-07 2026-01-22 Fertin Pharma A/S Dissolvable orally adhering nicotine tablet
US20260157416A1 (en) * 2024-12-06 2026-06-11 Altria Client Services Llc Asymmetrically shaped oral product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526020A (en) * 1975-12-24 1978-09-27 Life Savers Inc Confectionary tablets
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
US7067149B1 (en) * 1998-11-06 2006-06-27 Ethypharm Fast disintegrating tablet
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
FI81004C (fi) * 1988-02-25 1990-09-10 Suomen Sokeri Oy Binde- och utspaedningsmedel pao basis av xylitol och foerfarande foer dess framstaellning.
US4997654A (en) 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5204115A (en) * 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
FR2670398B1 (fr) * 1990-12-14 1995-02-17 Roquette Freres Composition pulverulente directement compressible et procede d'obtention.
GB9100009D0 (en) 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
TW469135B (en) 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
RU2189227C2 (ru) * 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Быстро распадающиеся прессованные в формах материалы и способ их получения
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
GB9716432D0 (en) 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
CA2435546A1 (en) 2001-02-08 2002-08-15 Alice C. Martino Rapid-onset medicament for the treatment of sexual dysfunction
EP1369109A1 (en) 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Preparations quickly disintegrating in oral cavity
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US20030215502A1 (en) 2002-03-20 2003-11-20 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
MXPA05007346A (es) 2003-02-04 2005-09-30 Gumlink As Tableta de goma de mascar comprimida.
WO2004068965A1 (en) * 2003-02-04 2004-08-19 Gumlink A/S Compressed chewing gum tablet
US7223072B2 (en) 2004-01-27 2007-05-29 Honeywell International, Inc. Gas turbine engine including airfoils having an improved airfoil film cooling configuration and method therefor
CN1946303B (zh) 2004-04-20 2011-02-16 Wm.雷格利Jr.公司 使口气清新的糖果产品及其制造和使用的方法
WO2006063189A2 (en) 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
EP1863466B1 (en) 2005-03-03 2017-08-09 Takasago International Corporation (USA) Synergistic salivation components
CN1327865C (zh) 2005-06-03 2007-07-25 贵州威门药业股份有限公司 治疗咳喘的中药制剂及其制备方法
EP1738657A3 (en) 2005-06-28 2007-01-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Sugar alcohol composition for tableting
WO2007074472A2 (en) * 2005-12-27 2007-07-05 Jubilant Organosys Limited Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide
ATE462416T1 (de) 2006-08-04 2010-04-15 Ethypharm Sa Mehrschichtige im mund zerfallende tablette
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
WO2009016133A1 (en) 2007-07-27 2009-02-05 Cargill, Incorporated Micronization of polyols
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
EP2229157B1 (en) * 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
ES2377869T3 (es) 2008-09-04 2012-04-02 Cargill, Incorporated Fabricación de comprimidos de eritritol
AU2010223105B2 (en) 2009-03-09 2016-05-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
JP6521564B2 (ja) 2010-12-22 2019-05-29 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 速崩性の固体被覆剤形
US20120276199A1 (en) * 2011-04-01 2012-11-01 Dr. Reddy's Laboratories Limited Taste masked pharmaceutical formulations
WO2013091631A1 (en) 2011-12-22 2013-06-27 Fertin Pharma A/S Method of releasing nicotine from chewing gum
JP6040218B2 (ja) 2012-02-23 2016-12-07 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
WO2013171164A1 (en) 2012-05-14 2013-11-21 EJP Pharmaceutical ApS Compositions and formulations for the treatment of halitosis
WO2014185792A1 (en) 2013-05-17 2014-11-20 Ozospa Holdings Limited Oral healthcare product
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2016061486A1 (en) 2014-10-16 2016-04-21 Cargill, Incorporated Process for preparing a directly compressible erythritol & uses thereof
AU2015346374A1 (en) 2014-11-11 2017-04-27 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
JP6840849B2 (ja) 2016-11-18 2021-03-10 フェルティン ファルマ アー/エス 別個の結合剤及びエリスリトールを含む錠剤
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
EP3854383A1 (en) 2016-11-18 2021-07-28 Fertin Pharma A/S Oral delivery vehicle
US11058641B2 (en) * 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526020A (en) * 1975-12-24 1978-09-27 Life Savers Inc Confectionary tablets
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
US7067149B1 (en) * 1998-11-06 2006-06-27 Ethypharm Fast disintegrating tablet
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide

Also Published As

Publication number Publication date
AU2019269881A1 (en) 2020-10-22
CN112118833A (zh) 2020-12-22
JP2021524444A (ja) 2021-09-13
WO2019219144A1 (en) 2019-11-21
CA3096339C (en) 2023-08-29
CA3096339A1 (en) 2019-11-21
AU2019269881B2 (en) 2022-08-04
JP7475286B2 (ja) 2024-04-26
US20210106534A1 (en) 2021-04-15
US12102714B2 (en) 2024-10-01
US20190350847A1 (en) 2019-11-21
US11058633B2 (en) 2021-07-13
US20210290530A1 (en) 2021-09-23
EP3793531A1 (en) 2021-03-24

Similar Documents

Publication Publication Date Title
JP7475286B2 (ja) 医薬品活性成分に適した崩壊性経口錠剤
CA3096291C (en) An oral tablet suitable for fast release of active pharmaceutical ingredients
EP3793518B1 (en) An oral tablet for taste masking of active ingredients comprising non-directly compressible sugar alcohol particles
CN112118832B (zh) 用于活性成分的口含吸收的片剂剂型
EP3793534B1 (en) An oral tablet for delivery of active ingredients to the gastrointestinal tract
CN112118834B (zh) 用于诱导性唾液产生的经口片剂
EP3793520B1 (en) An oral tablet for delivery of active ingredients to the throat comprising non-directly compressible sugar alcohol particles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant